GREGORY J ORLOFF M.D. NPI 1750358776

NPI Details

Gregory J Orloff, M.D. is a hematology and oncology internal medicine in Fairfax, VA with 40 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Gregory J Orloff, M.D. NPI is 1750358776. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: YALE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1986

The provider's business location address is:

8613 LEE HWY # 200N
FAIRFAX, VA
ZIP 22031-171
Phone: (703) 208-3155
Fax: (703) 280-9596

The NPI 1750358776 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Nephelometry, test method using light (HCPCS:83883)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Uric acid level, blood (HCPCS:84550)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Unclassified drugs (HCPCS:J3490)
• Refilling and maintenance of portable pump (HCPCS:96521)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Magnesium level (HCPCS:83735)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Injection of drug or substance into vein (HCPCS:96374)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Folic acid level, serum (HCPCS:82746)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Thyroxine (thyroid chemical), free (HCPCS:84439)

The enumeration date for this NPI number is 3/8/2006 and was last updated on 10/24/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.